Meetings

The meetings of the New England Society of Pathologists are scheduled individually each year, and posted to this site when dates are set.  

 

NEXT MEETING

Tuesday, September 9, 2025  6-8 PM at the Royal Sonesta in Cambridge

“Expanding on the Legacy of Dr. Robert E. Scully in the Era of Molecular Pathology” by Kyle M. Devins, MD

Register September 2025 NESP Meeting

Recent Past Meetings

May 20, 2025  Sponsored by BWH
David J. Papke Jr., MD, PhD.
 “Novel Mesenchymal Tumor Types and Biases in the Molecular Era"
April 25, 2025 MSP & NESP Joint Meeting in honor of The Desiree Carlson, MD Lecture
Dr. Faisal Mahmood, PhD
AI Pathology topic
November 12, 2024- Hubert J.Wolfe, MD Lecture sponsored by Tufts Medical Center
Dr. Knarik Arkun MD, FCAP
Unfreeze Your Mind: Brain Tumors After Hours”
September 24, 2024- Robert E. Scully Lecture sponsored by MGH
Drucilla J. Roberts, MD, MS

“Exploring the Depths of Gestational Trophoblastic Diseases: Going Beyond the Surface”

June 11, 2024- Ramzi Cotran, MD Lecture sponsored by Brigham & Women’s Hospital
Mia S. Desimone MD, MPH

Development and Implementation of Pathology Quality and Safety Rounds across Mass General Brigham Pathology"

Feb 13, 2024-Desire Carlson MD Lecture (annual joint meeting MSP-NESP)
Ming Zhou, MD, PhD from Tufts Medical Center 
“Prostate Cancer Pathology: An Update”

November 14, 2023 – Hubert J.Wolfe, MD Lecture (sponsored by Tufts Medical Center)
Dr. Marilyn Bui, MD, Ph
Artificial intelligence in pathology practice

September 19, 2023 – Robert E. Scully Lecture (sponsored by Massachusetts General Hospital) 
Dr. William FaquinMD, PhD 
"Salivary Gland Neoplasia: Updates & Challenges in Diagnosis and Treatment"

June 27, 2023 – Shields Warren, MD Lecture (sponsored by Beth Israel Deaconess Medical Center)
Paul VanderLaan MD, PhD 
“Update on Diagnostics and Ancillary Testing of Non-Small Cell Lung Cancer”

May 16, 2023 – Ramzi Cotran, MD Lecture (sponsored by Brigham and Women's Hospital)
Carlos Parra-Herran MD 
"Diagnosis and Management of Endometrial Carcinoma an Ever-Moving Target"